Free Trial
ETR:COP

CompuGroup Medical SE & Co. KGaA (COP) Stock Price, News & Analysis

CompuGroup Medical SE & Co. KGaA logo
€22.50 -0.16 (-0.71%)
As of 04/3/2025

About CompuGroup Medical SE & Co. KGaA Stock (ETR:COP)

Key Stats

Today's Range
€22.50
€22.86
50-Day Range
€22.10
€23.50
52-Week Range
€13.10
€40.84
Volume
34,691 shs
Average Volume
68,245 shs
Market Capitalization
$1.16 billion
P/E Ratio
46.15
Dividend Yield
4.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer & Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, consumer portals, and mobile apps; and operates telematics infrastructure business, which offers secure links, as well as security solutions for service providers. The company was founded in 1987 and is headquartered in Koblenz, Germany.

Remove Ads
Receive COP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CompuGroup Medical SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

COP Stock News Headlines

Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
CompuGroup Medical SE & Co. KGaA (CMPUY)
See More Headlines

COP Stock Analysis - Frequently Asked Questions

CompuGroup Medical SE & Co. KGaA's stock was trading at €21.76 at the start of the year. Since then, COP stock has increased by 3.4% and is now trading at €22.50.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that CompuGroup Medical SE & Co. KGaA investors own include Netflix (NFLX), Whiting Petroleum (WLL), NovelStem International (HOLL), (KOG) (KOG), Microchip Technology (MCHP), Meta Platforms (META) and NVIDIA (NVDA).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Health Information Services
Sub-Industry
Petroleum And Natural Gas
Current Symbol
ETR:COP
CIK
N/A
Fax
N/A
Employees
9,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
46.15
Forward P/E Ratio
9.07
P/E Growth
1.64
Net Income
$25.13 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.15 billion
Cash Flow
€0.95 per share
Price / Cash Flow
23.57
Book Value
€12.29 per share
Price / Book
1.83

Miscellaneous

Free Float
N/A
Market Cap
$1.16 billion
Optionable
Not Optionable
Beta
0.88
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (ETR:COP) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners